Do subjective symptoms of obstructive voiding correlate with post-void residual urine volume in women?
- 29 July 2004
- journal article
- clinical trial
- Published by Springer Nature in International Urogynecology Journal
- Vol. 16 (1) , 12-14
- https://doi.org/10.1007/s00192-004-1202-4
Abstract
The objective was to determine if symptoms of obstructive voiding correlate with post-void residual urine volume measured by catheterization. A cross-sectional study of 134 consecutive women referred to a tertiary urogynecology clinic was performed. Subjects were interviewed regarding three types of obstructive voiding symptoms: a sensation of incomplete emptying, straining to void, and slow urine stream. Post-void residual urine volume was measured by catheterization as the gold standard. Data for each symptom were analyzed using Cohen's kappa test, sensitivity, specificity, likelihood ratios for a positive of negative test, and positive and negative predictive values. A total of 11 out of 134 patients (8%) had a post-void residual volume greater than 100 ml. Of these 11, 1 had symptoms of incomplete emptying (9%), 1 had symptoms of straining to void (9%), and 2 had symptoms of slow urine stream (18%). Sensitivity, specificity, likelihood ratio for a positive symptom, likelihood ratio for a negative symptom, positive predictive value, negative predictive value, and Cohen's kappa, respectively, were 9%, 80%, 0.47, 1.13, 4%, 91%, and 0.05 for the symptom of incomplete emptying, 9%, 91%, 1.12, 1.0, 8%, 92%, and 0.01 for straining to void, and 18%, 89%, 1.6, 0.92, 13%, 92%, and 0.07 for the symptom of slow urine stream. It was concluded that symptoms of obstructive voiding do not correlate with measured post-void urine volume. In clinically important situations, these symptoms cannot substitute for measurement of post-void residual urine volume.Keywords
This publication has 17 references indexed in Scilit:
- Prospective, Randomized, Double-Blind Study of the Efficacy and Tolerability of the Extended-Release Formulations of Oxybutynin and Tolterodine for Overactive Bladder: Results of the OPERA TrialMayo Clinic Proceedings, 2003
- The Evaluation of Stress Incontinence Prior to Primary SurgeryJournal of Obstetrics and Gynaecology Canada, 2003
- Bladder outlet obstruction in women: prevalence, recognition, and management.Current Urology Reports, 2001
- Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study.2001
- Prospective Randomized Controlled Trial of Extended-Release Oxybutynin Chloride and Tolterodine Tartrate in the Treatment of Overactive Bladder: Results of the OBJECT StudyMayo Clinic Proceedings, 2001
- Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladderUrology, 2001
- THE SIGNIFICANCE OF THE AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX SCORE IN THE EVALUATION OF WOMEN WITH BLADDER OUTLET OBSTRUCTIONJournal of Urology, 2000
- Evaluation of a new once-daily formulation of oxybutynin for the treatment of urinary urge incontinenceUrology, 1999
- DO URINARY SYMPTOMS CORRELATE WITH URODYNAMIC FINDINGS?Journal of Urology, 1999
- ONCE DAILY CONTROLLED VERSUS IMMEDIATE RELEASE OXYBUTYNIN CHLORIDE FOR URGE URINARY INCONTINENCEJournal of Urology, 1999